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PASSENGER LEUKOCYTES. normal constituents of 
all organs. migrate after transplantation and produce 
persistent multilineage microchimerism. which modulates 
the recipient immune system and is suggested to have an 
important role in inducing graft acceptance after transplan-
tation.1.2 Leukocytes in the intestine have been shown to 
have inferior tolerogenic qualities compared with bone 
marrow (BM) cells; in addition. leukocytes have a lineage 
profile predisposed to graft-versus-host disease (GYHD).3 
We hypothesized that intestinal allograft alteration with 
ex-vivo irradiation will eliminate mature lymphoid elements 
from the graft without degrading the function of the 
epithelial components. Furthermore. we hypothesized that 
the replacement of irradiated graft passenger leukocytes 
with simultaneous donor BM infusion will improve the 
result of intestinal transplantation (SITx). This possibility 
was examined using the rat model of SITx. 
METHODS 
Inbred male Lewis (LEW. RT11) and Brown Norway (BN, RTln) 
rats were purchased from Harlan Sprague DaWley. Inc .• (indianap-
olis, IN) and used as donors and recipients. respectively. Small 
intestinal grafts were obtained from LEW donors and ex vivo 
irradiated from 137CS source before orthotopic SITx. Donor BM 
was obtained by flushing the tibias and femurs. and a total of 2.5 x 
108 cells was intravenously infused into recipients on the dav of 
SITx. FK 506 (l mg/kg/d) was intramuscularly given to recipi~nts 
on days 0-13. 20. and 21, Percentages of donor Ieukocvtes were 
determined sequentially in recipient blood by flow cvtom~try using 
monoclonal antibodies specific for major histocompatibility com-
plex (MHC) class I antigens on LEW and BN. 
RESULTS 
All recipients of unmodified intestinal grafts died of G VHD 
despite simultaneous donor BM infusion in some cases. 
Median survivals were 63 and 51 davs with and without 
simultaneous donor BM infusion. respectively (n = 5 for 
each). Graft irradiation (10 Gy) effectively prevented 
GVHD. and median animal sUlVival was prolonged to 92.5 
days without BM infusion. Further prolongation was 
achieved by adjunct BM. All animals in this group sUlVived 
for more than 100 days (n = 6). Percentages of donor cells 
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in the peripheral blood correlated with animal sUlVival. 
Donor phenotype cells remained at low levels (less than 
2f7c) after transplantation of lO-Gy irradiated grafts. 
whereas they were consistently high in GVHD recipients of 
unaltered grafts. No major histopathological abnormalities 
caused by irradiation. such as irradiation vasculopathy, were 
found in to Gy irradiated grafts 100 to 200 days after SITx. 
DISCUSSION 
SUlVival of graft passenger leukocytes was proved when 
donor leukocytes (microchimerism) were found in recipi-
ents whose allografts had been functioning for decades. 1,2 
The implication was that donor hematopoietic progenitor 
cells. including prulipotent stem cells. present in the trans-
planted organ had migrated and sUlVived in the recipient. 
Before this finding, transplantation had been defined 
largely in terms of a unidirectional immune reaction. and 
this one-way paradigm had failed to elucidate numerous 
enigmatic obselVations. including the surprising clinical 
success of organ transplantation. The discovery of micro-
chimerism has provided new insights into the immunologi-
cal events following organ transplantation and prompted 
the development of new strategies. 
In the field of SITx. GVHD has been a major concern 
since Monchik and Russell showed the development of 
GVHD in semiallogenic SITx using the parent-to-offspring 
Fl hybrid model.4 In fact. previous studies of intestinal graft 
modification have attempted to reduce the risk of GVHD 
using irradiation. antilymphocyte serum. or surgical manip-
ulation. Based on the recent discovery of microchimerism 
and the current understanding of the dual immune reaction 
after organ transplantation (host-versus-graft [HVG] and 
graft-versus-host [GVH]). we have examined methods of 
intestinal graft conditioning and recipient immune modu-
lation. This study shows the beneficial effects of graft 
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irradiation and adjuncti\'e donor 8M infusion on graft 
survival. Preliminary results suggest that the superiority of 
this strategy is associated with the rapid replacement of 
graft lymphoid tissues with recipient leukoCYtes of the same 
lineages. Further study is currently underwa\' to improve 
SITx from its present state of excessive mortality and 
morbidity. 
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